Evidence map›Paper›PMID 40113913›Full record

ArticleLeukemia2025

Outcomes of frailty subgroups of older adults (age ≥ 70) treated with teclistamab: an International Myeloma Foundation immunotherapy database real-world analysis.

Hira Mian, Thomas G Martin, Gregory R Pond, Sireesha Asoori, Rakesh Popat, Efstathios Kastritis, Joaquin Martinez-Lopez, Nadine Abdallah, Saurabh Chhabra, Ricardo Parrondo and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Hira MianMcMaster University, Hamilton, Canada. mianh@mcmcmaster.ca.
Thomas G MartinUniversity of California, San Francisco, CA, USA.
Gregory R PondMcMaster University, Hamilton, Canada.ORCID http://orcid.org/0000-0003-1033-0882
Sireesha AsooriUniversity of California, San Francisco, CA, USA.
Rakesh PopatUniversity College London, London, UK.
Efstathios KastritisDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
Joaquin Martinez-LopezUniversity of Complutense, Hospital 12 de Octubre, CNIO, i+12, Madrid, Spain.ORCID http://orcid.org/0000-0001-7908-0063
Nadine AbdallahMayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-9195-1589
Saurabh ChhabraMayo Clinic, Phoenix, AZ, USA.
Ricardo ParrondoMayo Clinic, Jacksonville, FL, USA.ORCID http://orcid.org/0000-0002-9314-9933
Sikander AilawadhiMayo Clinic, Jacksonville, FL, USA.ORCID http://orcid.org/0000-0002-8377-8111
Meletios A DimopoulosDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.ORCID http://orcid.org/0000-0001-8990-3254
Kwee YongUniversity College London, London, UK.ORCID http://orcid.org/0000-0002-6487-276X
Brian Gm DurieInternational Myeloma Foundation, Study City, CA, USA.
Saad Z UsmaniMemorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-5484-8731
Yi LinMayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-1556-6416
Carlyn Rose TanMemorial Sloan Kettering Cancer Center, New York, NY, USA. tanc4@mskcc.org.ORCID http://orcid.org/0000-0001-7922-2594

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40113913

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.